Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
These findings indicate that the treatments mentioned had a discernable effect on DED treatment, although with limited efficacy
Reference: Gorouhi F & Maibach HI (2015)
The once-daily subcutaneously administered GLP-1RA liraglutide (Victoza) was approved for the treatment of type 2 diabetes (in doses up to 1.8 mg) by the European Medicines Agency in 2009 and by the US Food and Drug Administration in 2010
The research helps set realistic expectations
GLP-1 medications help to stimulate the production of insulin, a hormone responsible for transporting glucose from the bloodstream into the body's cells for energy or storage
The science is solid
US$ 29.16
US$ 24.82
US$ 24.27
US$ 22.21
